Colonic exclusion and combined therapy for refractory constipation

Area of Science:

• Gastroenterology
• Surgical Innovation
• Colorectal Surgery

Background:

• Refractory constipation poses a significant clinical challenge.
• Surgical interventions are considered for severe, intractable cases.
• Evaluating novel surgical techniques is crucial for improving patient care.

Purpose of the Study:

• To compare the therapeutic effectiveness of colonic exclusion versus subtotal colectomy for refractory constipation.
• To assess key surgical outcomes and patient recovery metrics.

Main Methods:

• A randomized controlled trial involving 32 patients with refractory constipation.
• Treatment group (n=14): colonic exclusion with end-to-side colorectal anastomosis.
• Control group (n=18): subtotal colectomy with end-to-end colorectal anastomosis.

Main Results:

• Colonic exclusion group demonstrated significantly shorter surgical time (87 min vs 194 min), smaller incision length (10.4 cm vs 21.2 cm), and reduced blood loss (79.5 mL vs 286.3 mL).
• Hospital stay was also shorter in the colonic exclusion group (11.8 days vs 18.6 days).
• Recovery rates (85.7% vs 88.9%) and complication incidence (21.4% vs 33.3%) were comparable between groups.

Conclusions:

• Colonic exclusion is a more effective therapeutic strategy for refractory constipation.
• This method offers significant advantages including reduced surgical trauma and shorter hospital stays.
• Further research may explore long-term efficacy and patient-reported outcomes.